3.15 -0.15 (-4.55%)

New 52W Low in past week

21,551 XNAS Volume

XNAS 18 Mar, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Tivic Health Systems Inc is on 25 Mar 2025 for the purpose of Tivic Health Systems Inc Fourth Quarter Earnings Results for 2024 See details


Insider Trading disclosures for Tivic Health Systems Inc

The latest disclosure was made by Blake Gurfein in Tivic Health Systems Inc where a trade of 225,000 Restricted Stock Units done was reported to US exchanges on Dec. 18, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Blake Gurfein Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2024 225,000 225,000 - - Restricted Stock Units
Wolf Lisa G. Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2024 25,000 25,000 - - Restricted Stock Units
Zikria Dean Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2024 12,000 12,000 - - Stock Option (Right to Purchase)
Valauri Christina Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2024 12,000 12,000 - - Stock Option (Right to Purchase)
Ernst Jennifer Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2024 500,000 500,000 - - Restricted Stock Units
J. Bolton Sheryle Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2024 15,000 15,000 - - Stock Option (Right to Purchase)
Christina Valauri Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2024 3,000 3,000 - - Employee Stock Option (Right to Buy)
Dean Zikria Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2024 3,000 3,000 - - Employee Stock Option (Right to Buy)
Karen Drexler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2024 3,000 3,000 - - Employee Stock Option (Right to Buy)
Sheryle J. Bolton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2024 3,000 3,000 - - Employee Stock Option (Right to Buy)
Blake Gurfein Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2024 10,000 10,000 - - Employee Stock Option (Right to Buy)
Jennifer Ernst Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2024 32,000 32,000 - - Employee Stock Option (Right to Buy)
Kimberly Bambach Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2024 7,500 7,500 - 0 Common Stock
Jennifer Ernst Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2023 125,000 125,000 - - Employee Stock Option (Right to Buy)
Ryan Sabia Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2023 100,000 100,000 - - Employee Stock Option (Right to Buy)
Blake Gurfein Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2023 100,000 100,000 - - Employee Stock Option (Right to Buy)
Karen Drexler Director 31 Dec 2022 15,111 18,076 - 0 Common Stock
Dean Zikria Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 40,000 40,000 - - Employee Stock Option (Right to Buy)
Karen Drexler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 40,000 40,000 - - Employee Stock Option (Right to Buy)
Sheryle J. Bolton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 40,000 40,000 - - Employee Stock Option (Right to Buy)
Veronica Cai Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2022 117,880 117,880 - - Employee Stock Option (Right to Buy)
Ryan Sabia Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 50,000 50,000 - - Employee Stock Option (Right to Buy)
Blake Gurfein Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 35,000 35,000 - - Employee Stock Option (Right to Buy)
Jennifer Ernst Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 200,000 200,000 - - Employee Stock Option (Right to Buy)
Sheryle J. Bolton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2021 18,000 18,000 - - Employee Stock Option (Right to Buy)
Dean Zikria Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2021 18,000 18,000 - - Employee Stock Option (Right to Buy)
Ryan Sabia VP of Sales and Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2021 25,000 25,000 - - Employee Stock Option (Right to Buy)
Blake Gurfein Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2021 82,500 82,500 - - Employee Stock Option (Right to Buy)
Karen Drexler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2021 18,000 18,000 - - Employee Stock Option (Right to Buy)
Jennifer Ernst Director, Chief Executive Officer, Ten Percent Owner 12 Nov 2021 26,986 1,199,877 - 0 Common Stock
Jennifer Ernst Director, Chief Executive Officer, Ten Percent Owner 12 Nov 2021 1,391 1,172,891 - 0 Common Stock
Jennifer Ernst Director, Chief Executive Officer, Ten Percent Owner 12 Nov 2021 5,566 0 - - Series Seed-2 Convertible Preferred Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures